| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-5223(97)70114-4 |
| P698 | PubMed publication ID | 9240291 |
| P2093 | author name string | Cokkinos DV | |
| Geroulanos S | |||
| Khoury M | |||
| Dimopoulou I | |||
| Marathias K | |||
| Stavridis G | |||
| Daganou M | |||
| Prapas S | |||
| P2860 | cites work | The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination | Q29617876 |
| Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy | Q38982164 | ||
| Amiodarone: reevaluation of an old drug | Q40497822 | ||
| Treatment of perioperative low cardiac output syndrome | Q40581995 | ||
| Amiodarone-induced complications during coronary artery surgery | Q42261764 | ||
| Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation? | Q45080745 | ||
| Postoperative unilateral pulmonary edema: possible amiodarone pulmonary toxicity. | Q46434065 | ||
| Preoperative and Intraoperative Predictors of Inotropic Support and Long-Term Outcome in Patients Having Coronary Artery Bypass Grafting | Q51710664 | ||
| Anaesthesia and amiodarone. | Q51819684 | ||
| Conduction disturbances after open heart operation in a patient receiving amiodarone. | Q54022707 | ||
| Are patients receiving amiodarone at increased risk for cardiac operations? | Q54024501 | ||
| Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. | Q54161987 | ||
| Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery | Q67285927 | ||
| Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery | Q68091803 | ||
| Safety and efficacy of amiodarone. The low-dose perspective | Q68248858 | ||
| Fatal postoperative amiodarone pulmonary toxicity | Q68498086 | ||
| Amiodarone | Q68930408 | ||
| Cardiopulmonary effects of chronic amiodarone therapy in the early postoperative course of cardiac surgery patients | Q69466602 | ||
| QT prolongation and the antiarrhythmic efficacy of amiodarone | Q69990654 | ||
| Amiodarone pulmonary toxicity | Q70535120 | ||
| Danger of amiodarone therapy and elevated inspired oxygen concentrations in mice | Q70834556 | ||
| Amiodarone and the development of ARDS after lung surgery | Q72523768 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amiodarone | Q410061 |
| P304 | page(s) | 31-37 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
| P1476 | title | Low-dose amiodarone-related complications after cardiac operations | |
| P478 | volume | 114 |
| Q33827902 | Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment |
| Q74589348 | Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery |
| Q34005812 | Drug-induced respiratory disorders: incidence, prevention and management |
| Q51436144 | Duration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantation. |
| Q44212683 | Is KL-6 a serum indicator of early pulmonary fibrosis in childhood cancer patients? |
| Q33881186 | Observations on the perioperative management of patients undergoing the Maze procedure |
| Q40822126 | Pro: All patients should receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery |
Search more.